FASI-10: Translating Adversity into Action
Catch up on the Opening Remarks from Carlos Bosques, Ph.D., and Translating Adversity from Christine Olsen, M.D., and Lesley Solomon, M.B.A., from the 1st day of the FASI-10 Summit.
-
-
FASI-10: Foundations of FASI & a Decade of FASI Science
Keynote Speakers, Dr. Eric Lander and Dr. Ruslan Medzhitov from the 1st day of the FASI-10 Summit.
-
FASI-10: Beyond the Data – Patient Voices on Progress, Persistence, & What is Still Needed
Watch our Panel “Beyond the Data – Patient Voices on Progress, Persistence, & What is Still Needed” from the 1st day of our FASI-10 Summit, featuring Tamara Hubbard, MA, LCPC, Thomas Silvera, MSHS-PH, CST, Mia…
-
-
FASI-10: Engineering Tolerance: Novel Approaches to Food Allergy Treatment
Watch Session 2, Engineering Tolerance: Novel Approaches to Food Allergy Treatment, from our FASI-10 Summit on October 6th, 2026, featuring:
-
FASI-10: The Responder Problem: Why Food Allergy Therapies Work Differently Across Patients
Watch our panel, The Responder Problem: Why Food Allergy Therapies Work Differently Across Patients, from Day 1 of the FASI-10 Summit on October 6th, 2026, featuring:
-
FASI-10: Decoding Neuroimmune Circuits in Food Allergy
Watch Session3 of our FASI-10 Summit from October 6th, 2026 featuring:
-
FASI-10: From Vision to Pipeline: The FASI Food Allergy Medicines Accelerator
FASI’s CEO, Carlos Bosques Ph.D., give a keynote presentation at the FASI-10 Summit on October 7th, 2026 – From Vision to Pipeline: The FASI Food Allergy Medicines Accelerator
-
FASI-10: From Bench to Bedside: Next-generation Therapies in Food Allergy
Session 2 from the FASI-10 Summit on October 7th, 2026 featuring:
-
FASI-10: Challenges and Opportunities in Food Allergy Drug Development
Watch the FASI-10 Panel “Challenges and Opportunities in Food Allergy Drug Development” from October 7th, 2026, featuring:
-
FASI-10: Molecular Signatures: Unlocking Biomarkers for Food Allergy
Session 2 from the FASI-10 Summit on October 7th, 2026 featuring:
-
FASI-10: New Science and Solutions in Anaphylaxis
Session 3 from the FASI-10 Summit on October 7th, 2026 featuring:
